Title
Category
Credits
Event date
Cost
The Selective Use of Radiation in Solid Malignancies - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Radiation therapy is an integral part of cancer treatment across many disease sites, but the locoregional control benefits must be weighed against the potential toxicities. During this webinar, Kevin Pearlstein, MD, will review the role of radiation in cancer care including basic radiobiologic principles, logistics, and toxicities. He will discuss several recent studies examining the omission of radiation for different solid malignancies and review strategies to identify patients who will benefit the most from radiation.
Demystifying Molecular-Based Tests in Head and Neck Cancers - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Siddharth Sheth, DO, MPH, will provide a brief overview of clinical factors relevant to head and neck cancers and basic management. Themain focus will be the current use of technologies that aid with the diagnosis, treatment selection, and monitoring of patientswith head and neck cancers. This includes next generation sequencing assays for DNA sequencing, RNA sequencing, andcirculating tumor DNA. The goal of the presentation is for providers to be comfortable with ordering and basic interpretation ofthese tests.
Cardiovascular Toxicities of Cancer Therapies - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Gastrointestinal Cancer Management in North Carolina: Updates for 2020 - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Dr. Michael Lee from the UNC Lineberger Gastrointestinal Oncology group will describe relevant updates in systemic therapy for gastrointestinal cancers for health care providers throughout the state of North Carolina.
Update in ITP and TTP - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leading to low platelets, though the mechanism by which the platelets are consumed differs.  The lecture will update viewers on new therapies for the treatment of ITP and TTP
COVID-19 and Oncology Practice - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cancer. We will also review the impact of the pandemic on cancer care delivery, and emerging data regarding vaccination safety and efficacy.
Genitourinary Oncology Update 2021 - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.
Overview of CAR-T Cells and Toxicities - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial products for cancer patients.  This lecture will review the current treatments and their use in patients with hematologic malignancies.
Advances in Head and Neck Cancer Management in North Carolina: Updates for 2021 - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
Wendell Yarbrough, MD, MMHC, FACS, will lecture on multi-disciplinary treatment of head and neck cancer with updates regarding new techniques and treatment standards. This lecture will also give the audience updates on HPV-Associated Head and Neck Cancer with emerging therapeutic vulnerabilities. 

Pages